10.1002/adsc.201800305
Advanced Synthesis & Catalysis
1H), 8.62 (d, J = 8.5 Hz, 1H); 13C NMR (126 MHz, CDCl3)
δ 27.3, 27.3, 39.1, 39.7, 74.3, 114.5, 121.6, 123.9, 125.9,
126.4, 127.3, 128.0, 128.8, 133.5, 134.3, 139.9, 153.2,
175.3, 179.1; HR-MS [M+Na]+ 389.1732 [C23H26O4Na],
calculated 389.1723.
Harrak, C. Blaszykowski, M. Bernard, K. Cariou, E.
Mainetti, V. Mouries, A.-L. Dhimane, L. Fensterbank,
M. Malacria J. Am. Chem. Soc. 2004, 126, 8656-8657.
[4] For reviews, see: a) N. Marion, S. P. Nolan, Angew.
Chem. Int. Ed. 2007, 46, 2750-2752; b) R. K. Shiroodi,
V. Gevorgyan, Chem. Soc. Rev. 2013, 42, 4991-5001.
1H-Cyclopenta[a]naphthalene-1,3-diyl
bis(2,2-
dimethylpropanoate) 3h: Prepared according General
procedure 1 from 0.330 mmol of 1h; yield: 85% (102.4 mg,
0.279 mmol); yellow oil; TLC Rf 0.64 (Cyclohexane/EA
[5] A. Correa, N. Marion, L. Fensterbank, M. Malacria, S.
P. Nolan, L. Cavallo, Angew. Chem. Int. Ed. 2008, 47,
718-721.
1
20%); H NMR (400 MHz, CDCl3) δ 1.27 (s, 9H), 1.42 (s,
9H), 6.39 (d, J = 2.3 Hz, 1H), 6.64 (d, J = 2.3 Hz, 1H),
7.41−7.54 (m, 3H), 7.77−7.82 (m, 1H), 7.86−7.92 (m, 2H);
13C NMR (126 MHz, CDCl3) δ 27.2, 27.3, 39.2, 39.7, 74.2,
113.5, 117.0, 123.4, 125.6, 127.0, 129.0, 129.3, 129.8,
133.1, 136.4, 136.7, 151.4, 175.2, 178.7; HR-MS [M+Na]+
389.1683 [C23H26O4Na], calculated 389.1723.
[6] J. Jiang, Y. Liu, C. Hou, Y. Li, Z. Luan, C. Zhao, Z. Ke
Org. Biomol. Chem. 2016, 14, 3558-3563.
[7] For selected examples see: a) L. Zhang, S. Wang J. Am.
Chem. Soc., 2006, 128, 1442-1443. b) J. Zhao, C. O.
Hughes, F. D. Toste, J. Am. Chem. Soc. 2006, 128,
7436-7437; c) A. Buzas, F. Gagosz, J. Am. Chem. Soc.
2006, 128, 12614-12615; d) E Soriano, J. Marco-
Contelles, Chem. Eur. J. 2007, 13, 1350-1357; c) T.
Schwier, A. W. Sromek, D. M. L. Yap, D. Chernyak, V.
Gevorgyan, J. Am. Chem. Soc. 2007, 129, 9868-9878.
e) D. Leboeuf, A. Simonneau, C. Aubert, M. Malacria,
V. Gandon, L. Fensterbank, Angew. Chem. Int. Ed.
2011, 51, 6868-6871.
1H-indene-1,2-diyl bis(2,2-dimethylpropanoate) (4a):
By-product obtained during the optimization study (table
1
1); yellow oil; TLC Rf 0.70 (Cyclohexane/EA 20%); H
NMR (500 MHz, CDCl3) δ 1.30 (s, 9H), 6.81 (d, J = 12.3
Hz, 1H), 7.44−7.50 (m, 2H), 7.54−7.59 (m, 1H), 7.90−7.94
(m, 2H), 8.41 (d, J = 12.3 Hz, 1H); 13C NMR (126 MHz,
CDCl3) δ 26.8, 39.0, 109.9, 128.4, 128.7, 133.0, 138.0,
151.0, 174.6, 190.5; HR-MS [M+Na]+ 255.0980
[C14H16O3Na], calculated 255.0992.
(E)-3-Oxo-3-phenylprop-1-en-1-yl pivalate (2a):[11a] By-
product obtained during the optimization study (table 1);
1
yellow oil; TLC Rf 0.45 (Cyclohexane/EA 20%); H NMR
[8] a) N. Marion, S. Diez-Gonzalez, P. de Frémont, A. R.
Noble, S. P. Nolan, Angew. Chem. Int. Ed. 2006, 45,
3647-3650; b) N. Marion, P. Carlqvist, R. Gealagas, P.
de Frémont, F. Maseras, S. P. Nolan, Chem. Eur. J.
2007, 13, 6437-6451; c) P. Nun, S. Gaillard, A. M. Z.
Slawin, S. P. Nolan, Chem. Commun. 2010, 46, 9113-
9115; d) A. Gomez-Suarez, R. S. Ramon, O. Songis, A.
M. Z. Slawin, C. S. J. Cazin, S. P. Nolan,
Organometallics 2011, 30, 5463-5470; e) P. Nun, S.
Gaillard, A. Poater, L. Cavallo, S. P. Nolan, Org.
Biomol. Chem. 2011, 9, 101-104.
(500 MHz, CDCl3) δ 1.30 (s, 9H), 6.81 (d, J = 12.3 Hz, 1H),
7.44−7.50 (m, 2H), 7.54−7.59 (m, 1H), 7.90−7.94 (m, 2H),
8.41 (d, J = 12.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ
26.8, 39.0, 109.9, 128.4, 128.7, 133.0, 138.0, 151.0, 174.6,
190.5; HR-MS [M+Na]+ 255.0980 [C14H16O3Na],
calculated 255.0992.
Acknowledgements
We gratefully acknowledge the CNRS and the French Ministry of
Research. D.H. thanks the Agence Nationale de la Recherche
(Grant ANR-11-JS07-001-01 SyntHetAu) for a PhD fellowship.
[9] a) H. Buschmann, T. Christoph, in Analgesics; H.
Buschmann, T. Christoph, E. Friderichs, C. Maul, B.
Sundermann, Eds.; Wiley-VCH: Weinheim, 2002, 106
and references cited therein; b) Y. Ishiguro, K.
Okamoto, H. Sakamoto, Y. Sonoda, Nippon Nogei
Kagaku Kaishi 1993, 67, 1405-1410; c) M. P. Young,
O. C. Idowu, P. McKeown, (e-Therapeutics Ple, UK),
US Patent 20110212173, A1 20110901, 2011.
References
[1] a) A. S. K. Hashmi, Gold Bull. 2004, 37, 51-65; b) A. S.
K. Hashmi, Angew. Chem. Int. Ed. 2005, 44, 6990-
6993; c) S. P. Nolan, Nature 2007, 445, 496-497; d) A.
Fürstner, Chem. Soc. Rev. 2009, 38, 3208-3221. e)
Modern Gold Catalyzed Synthesis (Eds.: F. D. Toste, A.
S. K. Hashmi), Wiley-VCH, Weinheim, 2012. f) Gold
Catalysis: An Homogeneous Approach, Catalytic
Science Series, Vol. 13 (Eds.: F. D. Toste, V. Michelet),
Imperial College Press, London, 2014.
[10] For a review on the synthesis of indenes derivatives,
see: a) B. Gabriele, R. Mancuso, L. Veltri, Chem. Eur.
J. 2016, 22, 5056-5094; For selected recent examples in
gold catalysis, see: b) X. Yin, M. Mato, A. M.
Echavarren, Angew. Chem. Int. Ed. 2017, 56, 14591-
14595; c) M. Alvarez-Perez, M. Frutos, A. Viso, R.
Fernandez de la Pradilla, M. C. de la Torre, M. A.
Sierra, H. Gornitzka, C. Hemmert, J. Org. Chem. 2017,
82, 7546-7554; d) A. M. Sanjuan, C. Virumbrales, P.
Garcia-Garcia, M. A. Fernandez-Rodriguez, R. Sanz,
Org. Lett. 2016, 18, 1072-1075; e) A. Preinfalk, A.
Misale, N. Maulide, Chem. Eur. J. 2016, 22, 14471-
14474; f) N. Morita, M. Miyamoto, A. Yoda, M.
Yamamoto, S. Ban, Y. Hashimoto, O. Tamura,
Tetrahedron Lett. 2016, 57, 4460-4463; g) B. Ma, Z.
Wu, B. Huang, L. Liu, J. Zhang, Chem. Commun. 2016,
52, 9351-9354.
[2]For recent reviews, see: a) A. M. Asiri, A. S. K. Hashmi,
Chem. Soc. Rev. 2016, 45, 4471-4503; b) D. Pflästerer,
A. S. K. Hashmi, Chem. Soc. Rev. 2016, 45, 1331-1367;
c) W. Zi, F. Dean Toste, Chem. Soc. Rev. 2016, 45,
4567-4589; d) Z. Zheng, Z. Wang, Y. Wang, L. Zhang,
Chem. Soc. Rev. 2016, 45, 4448-4458; e) R. Dorel, A.
M. Echavarren, Chem. Rev. 2015, 115, 9028-9072; f) B.
Ranieri, I. Escofet, A. M. Echavarren, Org. Biomol
Chem. 2015, 13, 7103-7118.
[3] a) V. Mamane, T. Gress, H. Krause, A. Fürstner, J. Am.
Chem. Soc. 2004, 126, 8654-8655; b) A. Fürstner, P.
Hannen, Chem. Commun. 2004, 2546-2547. c) Y.
6
This article is protected by copyright. All rights reserved.